New Dako Omnis RTU antibodies
Introduction of 16 new high quality FLEX RTU antibodies for Dako Omnis.
Results you can trust
The first and only FDA-approved and
CE-IVD marked PD-L1 test for use in
non-squamous NSCLC for OPDIVO® (nivolumab).
Review of Breast Cancer Diagnosis
In collaboration with leading experts, Agilent publishes a new comprehensive review on breast cancer diagnostic testing.
FISH on Dako Omnis
Breast Cancer Review
New comprehensive review on breast cancer diagnostic testing.
New Product Catalog Available
The 2016 Pathology Product Catalog is now available.
Events and Congresses
Meet us at congresses and events around the world.